Guanfacine: the calming ADHD med
Guanfacine (Intuniv) is a non-stimulant ADHD medicine that many people describe as calming. Who it is licensed for, its use in adults, doses, side effects, why you must not stop it suddenly, and what users say.

Guanfacine started life as a blood pressure medicine. In a slow-release form, sold as Intuniv, it became an ADHD treatment, and it works quite differently from the stimulants: instead of revving things up, it calms an overactive alarm system in the brain. People often describe less anxiety, fewer emotional blow-ups and more ability to pause before reacting.
Key points
- Licensed for ADHD in young people. The US label rests on trials in ages 6 to 17, on its own or alongside a stimulant; the UK licenses it for children and young people.
- Adults use it off-label. A Japanese trial in adults found it helped, and in the UK NICE wants a specialist service involved.
- The main side effect is sleepiness, and it lowers blood pressure and heart rate. Many people take it in the evening.
- Never stop it suddenly. Blood pressure can bounce back above normal, so it is tapered off slowly.
How it works
Guanfacine activates alpha-2A receptors, which helps quiet the body’s “fight or flight” signals. The label says exactly how this helps ADHD isn’t known. It isn’t a stimulant, isn’t a controlled substance and, according to the label, has no known potential for abuse or dependence.
Who it is licensed for
| Where | What the license says |
|---|---|
| United States | ADHD, on its own or added to a stimulant. The trials behind it were in children and teens aged 6 to 17. |
| United Kingdom | Licensed for children and young people. NICE offers it, like atomoxetine, when methylphenidate and lisdexamfetamine didn’t suit or didn’t work. |
| Adults | Off-label. NICE says guanfacine for adults should be started only with advice from a specialist (tertiary) ADHD service. |
Find out what off-label means.
How much people take
| Step | US label |
|---|---|
| Start | 1 mg once a day, morning or evening, at about the same time |
| Increase | by no more than 1 mg a week |
| Target | 0.05 to 0.12 mg per kg a day, between 1 and 7 mg in total |
| Stopping | down by no more than 1 mg every 3 to 7 days |
- Swallow it whole. Crushing or chewing releases it too fast. Avoid taking it with a high-fat meal.
- Tablets: 1, 2, 3 and 4 mg, slow-release.
- Not the same as old-style guanfacine. Immediate-release tablets aren’t swapped milligram for milligram.
- In the Japanese adult trial, people went from 2 mg up to 4 to 6 mg a day.
Side effects
In two fixed-dose trials in children and teens (513 on guanfacine, 149 on placebo):
| Side effect | Guanfacine | Placebo |
|---|---|---|
| Sleepiness | 38% | 11% |
| Headache | 23% | 19% |
| Tiredness | 14% | 3% |
| Stomach ache | 11% | 9% |
| Low blood pressure | 7% | 3% |
| Dizziness | 6% | 4% |
| Nausea | 6% | 2% |
| Dry mouth | 4% | 1% |
Sleepiness rose with the dose: about half of children on 4 mg reported it. About 11 in 100 stopped because of side effects, against 3 in 100 on placebo. Blood pressure and pulse dropped a little on average.
In the adult trial, the most common side effects were sleepiness, thirst, lower blood pressure, dizziness on standing and constipation, and about 1 in 5 adults on guanfacine stopped because of them.
Good to know
- Stay hydrated and avoid overheating, especially if you faint easily.
- Go easy on alcohol and other sedating medicines; the label advises against alcohol.
- Don’t drive until you know how sleepy it makes you.
- Heart rhythm problems and other blood pressure medicines mean closer checks.
Medicines that don’t mix
- Ketoconazole, fluconazole and other CYP3A4 blockers raise guanfacine levels: the dose is usually halved.
- Rifampin, efavirenz, carbamazepine and other CYP3A4 boosters lower them: the dose may need doubling.
Does it work?
In children and teens, yes: that is what its license rests on. In adults, the strongest trial is from Japan. In 201 adults over 10 weeks, symptoms fell clearly more on guanfacine than on placebo, and doctors rated 48% as much improved, against 23% on placebo. The gains held over a 50-week follow-up study. The catch is tolerability: a 2025 review of adult trials found that adults were much more likely to stop guanfacine than placebo.
Off-label uses people ask about
| Use | Studies | What happened |
|---|---|---|
| Tics with ADHD | 34 children, 2001; 34 children with the slow-release form, 2017 | The 2001 trial found fewer tics and better ADHD scores; the 2017 pilot found no meaningful effect on tics |
| PTSD | Two small trials in veterans, 2006 and 2008 | No better than placebo |
| Anxiety and emotional control | Few trials | Heavily discussed by patients (below), but little tested |
What people say
From 14 Reddit threads about guanfacine or Intuniv, plus Google’s snippets of related threads. These are personal stories, not evidence.
- Less anxiety (11 threads). “Intuniv/Guanfacine (an ADHD medication) reduced my anxiety by about 70%!” (r/antidepressants)
- Better emotional control (7 threads). “It really helped my hyperactivity-impulsivity side of my ADHD… helps anxiety too, and definitely emotion regulation which was a big deal for me.” (r/adhd_anxiety)
- A body that relaxes. “It gently pushes me to be able to take a deeper breath” (r/adhd_anxiety).
- A pause before overwhelm. “It made me feel calmer and able to pause before getting overwhelmed.” (r/ADHD)
- Calm, but sometimes too calm. The same thread’s title: “Guanfacine makes me less anxious, which is great…except that I can’t DO anything”. Tell your prescriber if motivation drops.
- Sleepy, so taken at night. “Guanfacine doesn’t help my ADHD but does address my C-PTSD related anxiety/panic attacks. It did make me sleepy so initially i took it at night” (r/adhd_anxiety).
- Paired with a stimulant (5 threads). Someone on 2 mg guanfacine plus Adderall: “I am so relaxed when giving presentations at work.” (r/adhd_anxiety)
Where to get it
Guanfacine is a prescription medicine, and the online pharmacies we list don’t sell it. If your prescriber can’t offer it, atomoxetine is the other licensed non-stimulant and is widely available, including as the Indian brand Axepta.
Questions people ask
Is guanfacine a stimulant?
No. It works on alpha-2A receptors, not dopamine, isn’t a controlled substance and has no known potential for abuse or dependence.
Can adults take guanfacine for ADHD?
Many do, off-label. A Japanese trial in 201 adults found it helped, but more people stopped it because of side effects. In the UK, NICE wants a specialist ADHD service to advise.
Does guanfacine help anxiety?
Many people on Reddit say it does, and it is thought to dampen the body’s stress response. It hasn’t been well tested as an anxiety treatment, and two small trials found no benefit in PTSD.
Should I take guanfacine in the morning or at night?
The label allows either, at about the same time each day. Because sleepiness is the most common side effect, many people take it in the evening; agree the timing with your prescriber.
Can I stop guanfacine suddenly?
No. Stopping suddenly can push blood pressure and heart rate up sharply. The dose is lowered by no more than 1 mg every 3 to 7 days.
Sources
Checked 17 October 2026.
- Intuniv (guanfacine extended-release) prescribing information — Takeda, via DailyMed
- Attention deficit hyperactivity disorder: diagnosis and management (NG87), recommendations 1.7.10 and 1.7.17 — NICE (UK)
- Guanfacine extended-release in adults with ADHD, randomized placebo-controlled phase 3 trial (Iwanami et al., 2020) — Journal of Clinical Psychiatry
- Long-term guanfacine extended-release in adults with ADHD, 50-week open-label extension (Iwanami et al., 2020) — BMC Psychiatry
- Interventions for ADHD in adults, component network meta-analysis (Ostinelli et al., 2025) — The Lancet Psychiatry
- Guanfacine in children with tic disorders and ADHD, placebo-controlled trial (Scahill et al., 2001) — American Journal of Psychiatry
- Extended-release guanfacine for chronic tic disorders, pilot trial (Murphy et al., 2017) — Journal of Child and Adolescent Psychopharmacology
- No improvement of PTSD symptoms with guanfacine (Neylan et al., 2006) — American Journal of Psychiatry
- Guanfacine for PTSD in veterans, placebo-controlled trial (Davis et al., 2008) — Psychopharmacology Bulletin